|
Watson’s Sanctura Generic OK’d As Court Denies Allergan’s Appeal
The Supreme Court has declined to take up Allergan’s patent infringement case against Watson regarding the overactive bladder drug Sanctura XR, leaving Allergan vulnerable to generic competition.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives